Design, Synthesis, and Pharmacological Evaluation of Benzimidazolo-thiazoles as Potent CXCR3 Antagonists with Therapeutic Potential in Autoimmune Diseases: Discovery of ACT-672125.

MLA

Caroff, Eva, et al. “Design, Synthesis, and Pharmacological Evaluation of Benzimidazolo-Thiazoles as Potent CXCR3 Antagonists with Therapeutic Potential in Autoimmune Diseases: Discovery of ACT-672125.” Journal of Medicinal Chemistry, vol. 65, no. 17, Sept. 2022, pp. 11533–49. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.2c00676.

APA

Caroff, E., Meyer, E. A., Äänismaa, P., Froidevaux, S., Keller, M., & Piali, L. (2022). Design, Synthesis, and Pharmacological Evaluation of Benzimidazolo-thiazoles as Potent CXCR3 Antagonists with Therapeutic Potential in Autoimmune Diseases: Discovery of ACT-672125. Journal of Medicinal Chemistry, 65(17), 11533–11549. https://doi.org/10.1021/acs.jmedchem.2c00676

Chicago

Caroff, Eva, Emmanuel A Meyer, Päivi Äänismaa, Sylvie Froidevaux, Marcel Keller, and Luca Piali. 2022. “Design, Synthesis, and Pharmacological Evaluation of Benzimidazolo-Thiazoles as Potent CXCR3 Antagonists with Therapeutic Potential in Autoimmune Diseases: Discovery of ACT-672125.” Journal of Medicinal Chemistry 65 (17): 11533–49. doi:10.1021/acs.jmedchem.2c00676.